Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 1
Submit an article Journal homepage
312
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland

Erkki J.O. Soini ESiOR Oy, Kuopio, FinlandCorrespondence[email protected]
,
Glenn Davies Merck Research Laboratories, Upper Gwynedd, PA, USA
,
Janne A. Martikainen ESiOR Oy, Kuopio, Finland; Department of Social Pharmacy, University of Kuopio, Kuopio, Finland
,
Henry X. Hu Global Outcomes Research and Reimbursement, Merck & Co., Inc., Whitehouse Station, NJ, USA
,
Kaan Tunceli Global Outcomes Research and Reimbursement, Merck & Co., Inc., Whitehouse Station, NJ, USA
&
Leo Niskanen Department of Medicine, Kuopio University Hospital and University of Kuopio, Kuopio, Finland
Pages 25-36 | Accepted 19 Oct 2009, Published online: 09 Nov 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Jesse D. Ortendahl, Amanda L. Harmon, Tanya G. K. Bentley & Michael S. Broder. (2017) A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies. Journal of Medical Economics 20:7, pages 767-775.
Read now
Glenn M. Davies, Ami Vyas & Carl A. Baxter. (2017) Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States. Journal of Medical Economics 20:7, pages 723-731.
Read now
J. Heinonen, T.H. Koskela, E. Soini & O.P. Ryynänen. (2015) Primary-care-based episodes of care and their costs in a three-month follow-up in Finland. Scandinavian Journal of Primary Health Care 33:4, pages 283-290.
Read now
Pedro A. Laires, Flavia Ejzykowicz, Tun-Ying Hsu, Baishali Ambegaonkar & Glenn Davies. (2015) Cost–effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal. Journal of Medical Economics 18:8, pages 565-572.
Read now
Nkechinyere Ijioma & Jennifer G Robinson. (2011) Lipid-lowering effects of ezetimibe and simvastatin in combination. Expert Review of Cardiovascular Therapy 9:2, pages 131-145.
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P Mikhailidis. (2010) To switch (statins) or not to switch? That is the question. Expert Opinion on Pharmacotherapy 11:18, pages 2943-2946.
Read now

Articles from other publishers (18)

Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch & Thomas Michaeli. (2022) Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany. Cardiovascular Drugs and Therapy 37:4, pages 683-694.
Crossref
Clara Marquina, Jedidiah Morton, Ella Zomer, Stella Talic, Sean Lybrand, David Thomson, Danny Liew & Zanfina Ademi. (2023) Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification. Value in Health 26:4, pages 498-507.
Crossref
Carlos Aguiar, Francisco Araujo, Gabriel Rubio-Mercade, David Carcedo, Silvia Paz, Jose María Castellano & Valentín Fuster. (2022) Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study. Journal of Health Economics and Outcomes Research, pages 134-146.
Crossref
Carlos Aguiar, Francisco Araujo, Gabriel Rubio-Mercade, David Carcedo, Silvia Paz, Jose María Castellano & Valentín Fuster. (2022) Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study. Journal of Health Economics and Outcomes Research 9:2.
Crossref
Akhil Sasidharan, Bhavani Shankara Bagepally, S. Sajith Kumar, Kayala Venkata Jagadeesh & Meenakumari Natarajan. (2022) Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies. PLOS ONE 17:6, pages e0264563.
Crossref
Clara Marquina, Ella Zomer, Sandra Vargas-Torres, Sophia Zoungas, Richard Ofori-Asenso, Danny Liew & Zanfina Ademi. (2020) Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness. PharmacoEconomics 38:10, pages 1095-1113.
Crossref
Jonas Hermansson & Thomas Kahan. (2017) Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe. PharmacoEconomics 36:2, pages 205-213.
Crossref
Erkki Soini, Christian Asseburg, Maarit Taiha, Kari Puolakka, Oana Purcaru & Riitta Luosujärvi. (2017) Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland. Advances in Therapy 34:10, pages 2316-2332.
Crossref
Erkki Soini, Jaana Joutseno & Marja-Liisa Sumelahti. (2017) Cost-utility of First-line Disease-modifying Treatments for Relapsing–Remitting Multiple Sclerosis. Clinical Therapeutics 39:3, pages 537-557.e10.
Crossref
Livio Garattini & Anna Padula. (2017) Cholesterol-lowering drugs: science and marketing. Journal of the Royal Society of Medicine 110:2, pages 57-64.
Crossref
Emma Aarnio, Maarit J. Korhonen, Risto Huupponen & Janne Martikainen. (2015) Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register. Atherosclerosis 239:1, pages 240-247.
Crossref
Elvira D’Andrea, Iveta Nagyova & Paolo Villari. 2015. A Systematic Review of Key Issues in Public Health. A Systematic Review of Key Issues in Public Health 33 64 .
Delphine De Smedt, Els Clays, Lieven Annemans, Frank Doyle, Kornelia Kotseva, Andrzej Pająk, Christof Prugger, Catriona Jennings, David Wood & Dirk De Bacquer. (2013) Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey. International Journal of Cardiology 168:2, pages 898-903.
Crossref
Steven Simoens & Peter R. Sinnaeve. (2012) Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy. Cardiovascular Drugs and Therapy 27:1, pages 49-60.
Crossref
Delphine De Smedt, Kornelia Kotseva, Dirk De Bacquer, David Wood, Guy De Backer, Jean Dallongeville, Lehto Seppo, Andrzej Pająk, Željko Reiner, Diego Vanuzzo, Borislav Georgiev, Nina Gotcheva & Lieven Annemans. (2012) Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. European Heart Journal 33:22, pages 2865-2872.
Crossref
Roberta Ara, Hasan Basarir & Sue Elizabeth Ward. (2012) Principles of health economic evaluations of lipid-lowering strategies. Current Opinion in Lipidology 23:4, pages 271-281.
Crossref
J A Martikainen, E J O Soini, D E Laaksonen & L Niskanen. (2011) Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies. European Journal of Clinical Nutrition 65:10, pages 1148-1155.
Crossref
F. van Nooten, G. M. Davies, J. W. Jukema, A. H. Liem, E. Yap & X. H. Hu. (2011) Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia. Netherlands Heart Journal 19:2, pages 61-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.